EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports

Resha Resmawati Shaleha, Anna Yuliana, Saeful Amin iD, Jutti Levita iD, Sri Adi Sumiwi

Clinical Pharmacology: Advances and Applications · 2025-09 · Volume 17 · 269-289

DOI: 10.2147/cpaa.s542721 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2025-09. Verfasst von Resha Resmawati Shaleha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Red yeast rice (RYR) is an Asian indigenous medicine that ferments Oryza sativa grains using the Monascus fungi, specifically Monascus purpureus. Monacolins, pigments, phenols, sterols, and benzopyrans, such as the mycotoxin citrinin, were proven to be present in RYR, contributing to its numerous effects. This study aims to provide a thorough overview of the in vitro and in vivo pharmacological activities of M. purpureus red yeast rice, its studies in humans, and a summary of recent case reports. A literature search was conducted on the PubMed database, using the keywords: "pharmacology activity of red yeast rice" filtered to free full text and articles published from 2014 to 2024 for in vitro and in vivo studies, to ensure the newest developments. In vitro and in vivo pharmacological activity studies of RYR and/or metabolites have confirmed antidyslipidemia, anti-inflammatory, and anticancer activities, whereas studies in humans have evidenced its activity in improving lipid profiles. Furthermore, case reports on red yeast rice supplements, published between 2020 and 2025, revealed Fanconi syndrome and kidney dysfunction as the main adverse events, mostly reported from Japan.

Schlagwörter

Stichwörter der Autor:innen

Monascus fungiangkakantidyslipidemiacomplementary and alternative medicinepharmacological activityred koji

Autor:innen und Institutionen

  • Doctoral Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
  • Faculty of Pharmacy, Bakti Tunas Husada University, Tasikmalaya, Indonesia.
  • Faculty of Health Sciences, Esa Unggul University, Jakarta, Indonesia.
  • Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
  • Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Sumedang, Indonesia.

ORCID-Profile: Saeful Amin, Jutti Levita

Zitieren

APA

Shaleha, R. R., Yuliana, A., Amin, S., Levita, J., & Sumiwi, S. A. (2025). Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports. Clinical Pharmacology: Advances and Applications, Volume 17, 269-289. https://doi.org/10.2147/cpaa.s542721

Vancouver

Shaleha RR, Yuliana A, Amin S, Levita J, Sumiwi SA. Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports. Clinical Pharmacology: Advances and Applications. 2025;Volume 17:269-289. doi:10.2147/cpaa.s542721

BibTeX
@article{Shaleha2025,
  author = {Shaleha, Resha Resmawati and Yuliana, Anna and Amin, Saeful and Levita, Jutti and Sumiwi, Sri Adi},
  title = {Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports},
  journal = {Clinical Pharmacology: Advances and Applications},
  year = {2025},
  volume = {Volume 17},
  pages = {269--289},
  doi = {10.2147/cpaa.s542721}
}
Kostenlos starten →